All members are welcome to join Annual General Meeting on Tuesday 26 March at 12:00 (noon) in Birmingham or via a livestream. It will receive reports on College activities over the last year and hand over the Presidency.
Whether you can help the College champion child protection, run invited reviews or represent the voice of trainees, we have some wonderful volunteering opportunities. Plus two new International Officer roles!
Our new report presents findings from services responsible for conducting child protection medical assessments. It shows positive national results in many areas, but a need to better protect our safeguarding workforce.
Dr Emily Parker is one of our new Clinical Fellows with the Clean Air Fund Partnership, and in her first blog, she describes how doctors are taking a more critical look at the impact of air pollution on children's health.
We hope you can join us on 25-27 March for our major event. With the input of more than 35 specialty groups, inspiring speakers and practical workshops, you can update your knowledge on what matters to you.
This course will help delegates to develop an approach to the management of common paediatric skin disorders and how to recognise rare and complex conditions that require specialist referral.
This course will be delivered virtually, via Zoom.
The Novel insulins Innovation Incubator call from the Type 1 Diabetes Grand Challenge is designed to support transformative research in the field of insulin development. This funding call is open to academic groups and small to medium size biotechnology and pharmaceutical companies without geographical restrictions.
Funding amount range
£250,001 to £500,000
JDRF - Glycaemic and beta cell monitoring in individuals at risk of type 1 diabetes
The aim of this call is advancing our understanding of glycaemic changes during disease progression in presymptomatic individuals (Stages 1 and 2), with the potential to improve progression biomarkers and monitoring their transition to clinical diagnosis (Stage 3).
The focus of this call is the improvement of current or new metabolic risk assessment tools and their integration into clinically and commercially utilized testing platforms.
Round 3 of the Epilepsy12 audit was delivered between 1 April 2017 and 31 March 2022. This page provides details on the methodology and data submission process for Round 3. This methodology extends to Round 4, Cohort 4.
The Government has recently set out a strategy in which they will review the guidance on 20mph limits and low traffic neighbourhoods in England. Reports now say that the Government is preparing to stop English councils from introducing new 20mph speed limits.
On 20 June 2023, the Epilepsy12 Youth Advocates were announced as joint winners of the Patient and Public Involvement Hero Award by the Healthcare Quality Improvement Partnership (HQIP). The award is one of five Clinical Audit Heroes Awards that are announced during the 2023 Clinical Audit Awareness...
Epilepsy is the commonest significant neurological disorder affecting children and young people. Published in July 2023, these latest results from Epilepsy12 provide insight into the diagnosis and care of children and young people with epilepsy, and the organisation of paediatric epilepsy services i...
15 February 2023 marks the 10-year anniversary of the death of Ella Adoo-Kissi-Debrah. Ella was the first person in the UK to have air pollution listed as a cause of death. Since her death, Ella’s mother Rosamund has campaigned tirelessly for clean air to become a human right.
On 17th November 2022, the Epilepsy 12 Youth Advocates were announced as the winners for the Richard Driscoll Memorial Award for outstanding patient involvement in clinical audit at the annual Healthcare Quality Improvement Partnership (HQIP) AGM.